336 related articles for article (PubMed ID: 15026266)
21. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
Chen QY; Rowley MJ; Mackay IR
Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
[TBL] [Abstract][Full Text] [Related]
22. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?
Nakajima M; Shimizu H; Miyazaki A; Watanabe S; Kitami N; Sato N
J Gastroenterol; 1999 Oct; 34(5):607-12. PubMed ID: 10535489
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune liver diseases.
McFarlane IG
Scand J Clin Lab Invest Suppl; 2001; 235():53-60. PubMed ID: 11712693
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
25. [Autoantibodies in hepatology].
Johanet C; Dubel L; Chazouillères O
Pathol Biol (Paris); 1999 Nov; 47(9):997-1005. PubMed ID: 10609280
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: a longitudinal study.
Mishima S; Omagari K; Ohba K; Kadokawa Y; Masuda J; Mishima R; Kinoshita H; Hayashida K; Isomoto H; Shikuwa S; Mizuta Y; Kohno S
Hepatogastroenterology; 2008; 55(81):221-7. PubMed ID: 18507111
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis.
Liaskos C; Norman GL; Moulas A; Garagounis A; Goulis I; Rigopoulou EI; Dalekos GN
Clin Chim Acta; 2010 Mar; 411(5-6):411-5. PubMed ID: 20026019
[TBL] [Abstract][Full Text] [Related]
28. Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease.
Alver A; Menteşe A; Karahan SC; Erem C; Keha EE; Arikan MK; Eminağaoğlu MS; Deger O
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):287-91. PubMed ID: 17516290
[TBL] [Abstract][Full Text] [Related]
29. Primary biliary cirrhosis and autoimmune cholangiopathy.
Vierling JM
Clin Liver Dis; 2004 Feb; 8(1):177-94. PubMed ID: 15062200
[TBL] [Abstract][Full Text] [Related]
30. Unique epitopes for carbonic anhydrase II autoantibodies related to autoimmune retinopathy and cancer-associated retinopathy.
Adamus G; Yang S; Weleber RG
Exp Eye Res; 2016 Jun; 147():161-168. PubMed ID: 27185162
[TBL] [Abstract][Full Text] [Related]
31. Antilactoferrin antibodies in autoimmune liver diseases.
Ohana M; Okazaki K; Hajiro K; Uchida K
Am J Gastroenterol; 1998 Aug; 93(8):1334-9. PubMed ID: 9707061
[TBL] [Abstract][Full Text] [Related]
32. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
33. Antinuclear autoantibodies in chronic liver diseases.
Konikoff F; Isenberg DA; Barrison I; Theodor E; Shoenfeld Y
Hepatogastroenterology; 1989 Oct; 36(5):341-5. PubMed ID: 2620901
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis.
Bittencourt PL; Farias AQ; Abrantes-Lemos CP; Goncalves LL; Goncalves PL; Magalhães EP; Carrilho FJ; Laudanna AA; Cançado EL
J Gastroenterol Hepatol; 2004 Aug; 19(8):873-8. PubMed ID: 15242489
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of non-organ-specific autoantibodies in a rural community from northeastern Brazil: a population-based study.
Cunha LM; Bittencourt PL; Abrantes-Lemos CP; Moreira A; Almeida D; Parana R; Andrade Z
Hum Immunol; 2012 Jan; 73(1):70-4. PubMed ID: 22027387
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis.
Hausdorf G; Roggenbuck D; Feist E; Büttner T; Jungblut PR; Conrad K; Berg C; Klein R
Clin Chim Acta; 2009 Oct; 408(1-2):19-24. PubMed ID: 19576873
[TBL] [Abstract][Full Text] [Related]
37. A spectrum of histopathologic findings in autoimmune liver disease.
Terracciano LM; Patzina RA; Lehmann FS; Tornillo L; Cathomas G; Mhawech P; Vecchione R; Bianchi L
Am J Clin Pathol; 2000 Nov; 114(5):705-11. PubMed ID: 11068543
[TBL] [Abstract][Full Text] [Related]
38. Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
Lindgren S; Glaumann H; Almer S; Bergquist A; Björnsson E; Broomé U; Danielsson A; Lebrun B; Prytz H; Olsson R
Eur J Intern Med; 2009 Jul; 20(4):398-402. PubMed ID: 19524182
[TBL] [Abstract][Full Text] [Related]
39. Detection of M2 antimitochondrial antibodies by dot blot assay is more specific than by enzyme linked immunosorbent assay.
Bargou I; Mankaï A; Jamaa A; Ben Jazia I; Skandrani K; Sfar H; Baccouche A; Ajmi S; Letaief A; Fabien N; Jeddi M; Ghedira I
Pathol Biol (Paris); 2008 Feb; 56(1):10-4. PubMed ID: 17604571
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune liver disease 2007.
Muratori P; Granito A; Pappas G; Muratori L; Lenzi M; Bianchi FB
Mol Aspects Med; 2008; 29(1-2):96-102. PubMed ID: 18067956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
